Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sanofi-Aventis S.A. ADR (SNY)

Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sanofi-Aventis S.A. ADR 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017

www.sanofi.com Employees: 86,088 P: 33-1-53-77-44-00 F: +33 153774303

Description:

Sanofi-Aventis manufactures & markets prescription drugs across countries. It focuses on major therapeutic areas such as multiple sclerosis, cardiovascular, immunology, neurology, oncology, rare blood disorders & diabetes, etc. By taking Genzyme Corporation as a subsidiary, it added products like Cerezyme, Myozyme/Lumizyme & Fabrazyme to its portfolio. Sanofi has become a major player in the CHC sector. It acquired many companies i.e. Ablynx & Bioverativ, Synthorx & Principia & Translate Bio and Kadmon. It has collaborated with companies like Regeneron among others. It develops and markets Dupixent, Kevzara & Libtayo in collaboration with Regeneron. Sanofi, along with Regeneron, is now solely responsible for Praluent marketing in & outside the U.S. Sanofi operates through 3 Global Business Units: Specialty Care (neurology & immunology, rare diseases, rare blood disorders & oncology), Vaccines & General Medicines (diabetes, cardiovascular & established products) and Consumer Healthcare, a standalone unit.

Key Statistics

Overview:

Market Capitalization, $K 121,079,824
Enterprise Value, $K 129,394,056
Shares Outstanding, K 2,537,829
Annual Sales, $ 50,266 M
Annual Net Income, $ 5,844 M
Last Quarter Sales, $ 15,567 M
Last Quarter Net Income, $ 3,095 M
EBIT, $ 10,835 M
EBITDA, $ 16,021 M
60-Month Beta 0.58
% of Insider Shareholders 1.00%
% of Institutional Shareholders 14.04%
Float, K 2,512,451
% Float 99.00%
Short Volume Ratio 0.19

Growth:

1-Year Return -1.04%
3-Year Return -4.25%
5-Year Return -6.19%
5-Year Revenue Growth 19.30%
5-Year Earnings Growth 35.91%
5-Year Dividend Growth 15.00%

Per-Share Information:

Most Recent Earnings 1.57 on 10/25/24
Next Earnings Date 02/06/25
Earnings Per Share ttm 4.35
EPS Growth vs. Prev Qtr 68.82%
EPS Growth vs. Prev Year 12.95%
Annual Dividend Rate, $ 1.48
Annual Dividend Yield 3.10%
Most Recent Dividend 1.478 on 05/09/24
Next Ex-Dividends Date 05/09/24
Dividend Payable Date 06/06/24
Dividend Payout Ratio 34.30%

SNY Ratios

Ratio
Price/Earnings ttm 10.92
Price/Earnings forward 11.70
Price/Earnings to Growth 1.29
Return-on-Equity % 27.45%
Return-on-Assets % 15.79%
Profit Margin % 11.63%
Debt/Equity 0.00
Price/Sales 2.59
Price/Cash Flow 7.43
Price/Book 1.53
Book Value/Share 0.00
Interest Coverage 6.45

SNY Dividends

Date Value
05/09/24 $1.4780
05/30/23 $1.3750
05/04/22 $1.2600
05/03/21 $1.3680
04/30/20 $1.1740
05/07/19 $1.1560
05/06/19 $1.7390
05/09/18 $1.2030
05/11/17 $1.0980
05/05/16 $1.1010
05/06/15 $1.6181
05/07/14 $1.9096
05/06/13 $1.8624
05/07/12 $1.7564
05/11/11 $1.8221
05/17/10 $1.6273
04/20/09 $1.4186
05/16/08 $1.5103
06/04/07 $1.1454
06/02/06 $0.9120
06/02/05 $0.7993
09/27/04 $0.0304
04/30/04 $0.5795
05/28/03 $0.4897
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar